Shanghai, China

Shin-Shay Tian

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Shanghai Vitalgen Biopharma Co., Ltd., Shanghai Vitalgen Biopharma Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shin-Shay Tian. Retrieved from https://idiyas.com/inventor/shin-shay-tian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Shin-Shay Tian

Introduction

Shin-Shay Tian is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the treatment of genetic disorders. His work focuses on developing innovative solutions that can improve the quality of life for patients suffering from rare diseases.

Latest Patents

Shin-Shay Tian holds a patent for "Recombinant adeno-associated viral vectors for treating Bietti Crystalline Dystrophy." This patent describes a recombinant adeno-associated vector that includes a codon-optimized sequence encoding CYP4V2, linked to selected gene expression regulatory sequences. This innovative approach aims to provide a therapeutic solution for individuals affected by Bietti Crystalline Dystrophy (BCD).

Career Highlights

Shin-Shay Tian is associated with Shanghai Vitalgen Biopharma Co., Ltd., where he continues to advance his research and development efforts. His work at this company has positioned him as a key player in the biotechnology sector, focusing on gene therapy and innovative treatment methodologies.

Collaborations

Shin-Shay Tian collaborates with notable colleagues, including Lu Guo and Yezheng Tao. These partnerships enhance the research environment and foster the development of groundbreaking therapies.

Conclusion

Shin-Shay Tian's contributions to biotechnology, particularly through his patent for treating Bietti Crystalline Dystrophy, highlight his role as an influential inventor. His ongoing work at Shanghai Vitalgen Biopharma Co., Ltd. continues to pave the way for innovative treatments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…